Edwards Lifesciences: Improving Patient Safety and Outcomes: EU-HYPROTECT Registry Demonstrates Reduced Time in Hypotension During Surgery Using Acumen HPI Software
Edwards Lifesciences today announced the results of the EU-HYPROTECT registry which indicates that using Acumen HPI software may help reduce the duration and severity of intraoperative hypotension in patients having non-cardiac surgery.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230608005565/en/
(Graph: Business Wire)
EU-HYPROTECT is a European multicenter prospective observational registry which included in its final analysis 702 patients scheduled for elective major non-cardiac surgery in 12 medical centers in 5 countries (France, Germany, Italy, Spain, UK). It is the first multicenter registry involving a predictive monitoring technology, establishing a large, prospectively collected data base on hypotension management in patients having non-cardiac surgery. All patients had intraarterial blood pressure monitoring with an arterial catheter and intraoperative Acumen HPI software.
Both the duration and severity of intraoperative hypotension are associated with postoperative complications. The primary endpoint of this registry, therefore, was intraoperative hypotension quantified using the time-weighted average mean arterial pressure (MAP) <65 mmHg. Secondary endpoints included the proportion of patients with at least one ≥1-min-episode of a MAP <65 mmHg, and the number of ≥1-min-episodes of a MAP <65 mmHg.
Between September 2021 and May 2022, 749 patients were enrolled in the registry and 702 included in the final analysis. The median time-weighted average MAP <65 mmHg was 0.03 (0.00, 0.20) mmHg. 285 patients (41%) had no ≥1-min-episode of a MAP <65 mmHg – 417 patients (59%) had at least one. The median number of ≥1-min-episodes of a MAP <65 mmHg was 1 (0, 3).
In addition, although the study was not powered for this outcome, the incidence of acute kidney injury was at the lower end of what is reported in patients having major non-cardiac surgery.
In Europe, of the 2.5 million patients undergoing high-risk surgery annually, one in four develops serious postoperative complications1,2. Throughout the hospital patient journey, anaesthetists and intensivists need to analyse large amounts of data to make life-critical decisions for patients. One example is critical drops in blood pressure known as hypotension. Intraoperative hypotension is common in patients having non-cardiac surgery under general anaesthesia3. Intraoperative hypotension is associated with increased mortality and major postoperative complications (myocardial injury, acute kidney injury)(4-8).
These postoperative complications come with a significant cost burden for healthcare systems as they are linked with rehospitalisations and increased morbidity.9
“Avoiding intraoperative hypotension is a complex task for anesthetists. Current hypotension treatment is mainly reactive, sometimes only being initiated after the blood pressure has already dropped below safe levels”, explains Prof. Bernd Saugel (Hamburg, Germany).
Edwards Lifesciences has developed the Acumen HPI software, which provides clinicians with information regarding the likelihood that a patient will develop hypotension. Based on an algorithm that calculates data from hemodynamic monitoring in perioperative management, it leverages predictive analytics to alert clinicians of potential blood pressure drops before they occur.
“Predictive hemodynamic monitoring may be a promising approach to help clinicians better manage hypotension. It is intriguing to investigate innovations that can support clinicians in clinical decision making and potentially improve quality of care,” comments Prof. Bernd Saugel (Hamburg, Germany).
“The consequences of the COVID-19 pandemic have drastically accelerated the need for solutions that improve patient safety and outcomes, reduce hospital length of stay and increase hospital efficiencies. The results of the EU-HYPROTECT registry are promising and demonstrate the need to better monitor hypotension in the perioperative pathway. Improving patient safety and outcomes is our ultimate goal and we believe the use of predictive monitoring can help achieve this.” comments Pr Thomas Scheeren, Senior Director Medical Affairs EMEACLA at Edwards Lifesciences.
The full results of the EU-HYPROTECT registry were published in the British Journal of Anaesthesia and can be consulted on https://www.bjaopen.org/article/S2772-6096(23)00019-9/fulltext
About Edwards Lifesciences
Edwards Lifesciences is the global leader of patient-focused innovations for structural heart disease and critical care monitoring. We are driven by a passion for patients, dedicated to improving and enhancing lives through partnerships with clinicians and stakeholders across the global healthcare landscape. For more information, visit www.Edwards.com and follow us on Twitter @EdwardsLifesci.
Edwards, Edwards Lifesciences, the stylized E logo, Acumen, Acumen HPI, HPI and Hypotension Prediction Index are trademarks of Edwards Lifesciences Corporation and its affiliates. All other trademarks are the property of their respective owners. This statement is made on behalf of Edwards Lifesciences Corporation and its subsidiaries.
1Preoperative Score to Predict Postoperative Mortality – POSPOM Edward’s Presentation
2Ghaferi AA et al. Variation in hospital mortality associated with inpatient surgery. N Engl J Med, 2009.
3Bijker JB, van Klei WA, Kappen TH, van Wolfswinkel L, Moons KG, Kalkman CJ: Incidence of intraoperative hypotension as a function of the chosen definition: literature definitions applied to a retrospective cohort using automated data collection. Anesthesiology 2007, 107(2):213-220.
4Gregory A, Stapelfeldt WH, Khanna AK, Smischney NJ, Boero IJ, Chen Q, Stevens M, Shaw AD: Intraoperative Hypotension Is Associated With Adverse Clinical Outcomes After Noncardiac Surgery. Anesth Analg 2020.
5Salmasi V, Maheshwari K, Yang D, Mascha EJ, Singh A, Sessler DI, Kurz A: Relationship between Intraoperative Hypotension, Defined by Either Reduction from Baseline or Absolute Thresholds, and Acute Kidney and Myocardial Injury after Noncardiac Surgery: A Retrospective Cohort Analysis. Anesthesiology 2017, 126(1):47- 65
6Sessler DI, Khanna AK: Perioperative myocardial injury and the contribution of hypotension. Intensive care medicine 2018, 44(6):811-822
7Sun LY, Wijeysundera DN, Tait GA, Beattie WS: Association of Intraoperative Hypotension with Acute Kidney Injury after Elective Noncardiac Surgery. Anesthesiology 2015, 123(3):515-523.
8Walsh M, Devereaux PJ, Garg AX, Kurz A, Turan A, Rodseth RN, Cywinski J, Thabane L, Sessler DI: Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension. Anesthesiology 2013, 119(3):507-515
9Vonlanthen R, Slankamenac K, Breitenstein S, Puhan MA, Muller MK, Hahnloser D, Hauri D, Graf R, Clavien PA. The impact of complications on costs of major surgical procedures: a cost analysis of 1200 patients. Ann Surg. 2011 Dec;254(6):907-13. doi: 10.1097/SLA.0b013e31821d4a43. PMID: 21562405.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
+41 (0)75 431 74 95
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Philip Morris International Receives Science-Based Targets initiative (SBTi) Validation for its Forest, Land, and Agriculture (FLAG) Emissions Reductions Targets21.9.2023 11:00:00 EEST | Press release
Philip Morris International Inc. (PMI) (NYSE: PM) announced today that the Science Based Targets initiative (SBTi) has verified its Forest, Land, and Agriculture (FLAG) emissions reductions targets. PMI is one of very few companies so far to achieve this recognition. Land use and agricultural sectors offer vast opportunities for GHG removals, including agroforestry, soil carbon sequestration, and forest restoration, for example. Adopting a science-based target for Forest, Land, and Agriculture will support PMI to further accelerate its efforts to reduce greenhouse gas (GHGs) emissions arising from land use. According to the Science Based Targets initiative, “SBTi’s FLAG guidance provides the world’s first standard method for companies in land-intensive sectors to set science-based targets that include land-based emission reductions and removals. The guidance enables companies to reduce the 22% of global greenhouse gas emissions from agriculture, forestry, and other land use.” PMI maint
Forrester To Recognise Return On Integration Honours And Programmes Of The Year Winners At Its B2B Summit EMEA 202321.9.2023 11:00:00 EEST | Press release
Forrester (Nasdaq: FORR) will recognise Keysight Technologies, as this year’s Return On Integration Honours winner at its B2B Summit EMEA, held October 9-11, 2023, in London, UK, and digitally. Keysight Technologies is being recognised for aligning its marketing, sales, and product functions to maximise customer value. Additionally, Forrester will celebrate Programmes Of The Year winners for outstanding achievements within specific functions of marketing, sales, and product: NTT Ltd. for developing a global account-based marketing center of excellence; and Dun & Bradstreet for transforming a regional marketing function into a centralised marketing hub. Forrester’s B2B Summit EMEA is the premier event for B2B marketing, sales, and product leaders to explore and learn new ideas, pragmatic frameworks, and compelling data to fuel their customer-obsessed growth engines. At the event, honourees will present how they have grown revenue, accelerated time to market, and launched integrated glob
New Report Outlines Power of External Data Sharing to Unlock Transformative Collaboration21.9.2023 10:30:00 EEST | Press release
Sharing data externally across ecosystems accelerates business value, enables greater collaboration, improves compliance and helps meet sustainability targets. However, many organizations have concerns about protecting their data, loss of intellectual property and meeting regulatory requirements, which can hold back external data sharing. To support companies in harnessing the transformative benefits of external data sharing, Arthur D. Little (ADL) and Pinsent Masons today published an in-depth Viewpoint outlining best practices, models, processes and key capabilities required to underpin success. Based on their experience and looking at common concerns, it explains how to overcome external data sharing challenges through a combination of regulatory/legal understanding and making the right strategic/technology decisions. Michaël Kolk, Global Practice Leader, Technology & Innovation Management, at Arthur D. Little, comments: “In an era of AI and digital transformation, businesses unders
Reply Unveils MLFRAME Reply, a Generative AI Framework for Knowledge Development and Sharing21.9.2023 10:30:00 EEST | Press release
Reply is pleased to announce the launch of MLFRAME Reply, a new generative artificial intelligence framework for heterogeneous knowledge bases. Developed by Machine Learning Reply, a specialised company within the group, MLFRAME Reply applies a proprietary methodology to analyze databases, train algorithms, and validate results on top AI technologies. This enables the rapid creation of conversational generative models applicable to specific corporate knowledge domains. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230921536625/en/ MLFRAME Reply is a framework that leverages Generative AI to create generative models applicable to specific knowledge domains. This aims to enhance the customer experience. (Photo: Reply) The current availability of generative artificial intelligence technologies makes large amounts of unstructured information and textual data accessible and queryable through natural language. It provides the abi
emnify and Skylo to Unveil the First Converged Cellular and Satellite Connectivity at Mobile World Congress21.9.2023 10:00:00 EEST | Press release
Today, emnify the leader in cloud-native IoT connectivity solutions, and Skylo, a global software-defined non-terrestrial network (NTN) operator focusing on connecting everything, everywhere, announce an industry-first convergence of satellite and cellular IoT connectivity from a single emnify SIM. Partnering with leading module manufacturer, Murata, the companies are expanding the next generation of IoT connectivity to space. The combination of emnify’s cloud-native, mobile core technology and direct IoT cellular access with providers around the globe, with Skylo’s NTN satellite access, provides seamless, intelligent, friction-free, network IoT connectivity. The emnify IoT SuperNetwork, the industry’s first cloud-native IoT connectivity service with direct access to over 540 cellular networks in over 180 countries, provides access to Skylo’s satellite NTN services, marking the first and only single SIM access to global IoT connectivity on terrestrial and non-terrestrial networks. This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom